Newsfeeds - Spark Newswire

1 minute read

News

Hepion Pharmaceuticals Announces Publication Of Food Effect Study With Rencofilstat

Today, 12:24 PM

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence ("AI")-driven therapeutic drug development for the treatment of non-alcoholic

HEPA

30 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 12:24 PM

During Wednesday's trading, 517 companies set new 52-week lows.

$APE

4 minute read

Important Biotech Catalysts For September 12, 2022 – End Of The Day Summary

By Ragothaman Srinivasan

Today, 12:24 PM

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Mersana Therapeutics’ (NASDAQ:MRSN) lead candidate…

ACAD

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 12:24 PM

ADAP

3 minute read

Hepion Pharmaceuticals Announces Initiation Of Phase 2b ‘ASCEND-NASH’ Trial

By Benzinga Newsdesk

Today, 12:24 PM

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic

HEPA

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

Today, 12:24 PM

Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million.

ABVC